Plomestane (MDL-18962; propargylestrenedione, PED) is a potent, steroidal, irreversible aromatase inhibitor which was under development by Marion Merrell Dow/Hoechst Marion Russell (now Hoechst AG) as an antineoplastic agent for the treatment of breast cancer. It may provide a mechanism for controlling estrogen responsive processes.

纯度：≥98%

CAS：77016-85-4